Clinical Trials Sponsored by Deerland Enzymes
Total 675 results
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
Genzyme, a Sanofi CompanyCompletedAdhesion PreventionFrance
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromesUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Netherlands
-
Genzyme, a Sanofi CompanyCompletedKidney Failure, ChronicUnited States, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellJapan
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2United States, France, Netherlands
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
Genzyme, a Sanofi CompanyCompletedAtherosclerosis | Intermittent Claudication | Peripheral Vascular DiseaseUnited States, United Kingdom, Germany
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, United Kingdom, Spain, Italy, Brazil, Canada, Poland
-
Genzyme, a Sanofi CompanyCompletedMusculoskeletal Diseases | Osteoarthritis, KneeBelgium, United Kingdom, France, Netherlands, Czech Republic, Germany
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, United Kingdom, Canada, Czech Republic, Hungary, Poland
-
Genzyme, a Sanofi CompanyTerminatedAdhesion Prevention (Abdominal)France, Sweden
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney Disease | HyperphosphataemiaFrance, Germany, Spain, Netherlands, Italy, Austria, Denmark
-
Genzyme, a Sanofi CompanyCompletedDose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on HemodialysisChronic Kidney Disease | Chronic Kidney Disease on HemodialysisChina
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney Disease | HyperphosphatemiaUnited Kingdom, Australia, Denmark, France, Germany
-
Genzyme, a Sanofi CompanyTerminatedNiemann-Pick Disease | Acid Sphingomyelinase DeficiencyUnited States
-
Genzyme, a Sanofi CompanyCompletedAntibiotic-Associated Diarrhea | Pseudomembranous Colitis | Clostridium Difficile DiarrheaCanada
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompletedIntestinal Obstruction | Digestive System Surgical ProceduresUnited States, United Kingdom, Canada, Germany, Netherlands
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, Renal CellUnited States
-
Genzyme, a Sanofi CompanyCompletedCerebroside Lipidosis Syndrome | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease Type I | Clucocerebrosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)United States, Netherlands, United Kingdom, Germany
-
Genzyme, a Sanofi CompanyCompletedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Relapsed LeukemiaUnited States
-
Genzyme, a Sanofi CompanyCompletedChronic Kidney DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedSolid TumorsUnited States
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaUnited States
-
Genzyme, a Sanofi CompanyCompletedDiarrhea | Clostridium EnterocolitisAustralia, Belgium, France, Spain, Germany, Portugal, Switzerland, Austria, United Kingdom, Ireland, Czech Republic, Denmark, Norway, Sweden
-
Genzyme, a Sanofi CompanyCompletedAutologous Stem Cell TransplantationUnited States
-
Genzyme, a Sanofi CompanyCompletedHodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease | Glycogenesis 2 Acid Maltase DeficiencyUnited States, Canada, Australia
-
Genzyme, a Sanofi CompanyApproved for marketing
-
Genzyme, a Sanofi CompanyCompletedFamilial HypercholesterolemiaNetherlands, France, Germany, Sweden, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedLymphoma | Multiple Myeloma | Non Hodgkin's Lymphoma | Hodgkin's DiseaseGermany
-
Genzyme, a Sanofi CompanyCompletedHIV Infections | X4 Tropic VirusUnited States, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogenesis 2 Acid Maltase Deficiency | Pompe Disease (Late-Onset) | Glycogen Storage Disease Type II (GSD II)France
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
Genzyme, a Sanofi CompanyWithdrawn
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II | Glycogenosis 2
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
Genzyme, a Sanofi CompanyTerminatedCrohn DiseaseIsrael, United States, Romania, Ukraine, South Africa, Canada, Australia, Bulgaria, Russian Federation, New Zealand, Brazil
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyTerminated